Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-24

FDA Approved: PRUCALOPRIDE — Original Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s original application for prucalopride. It is indicated for the treatment of chronic idiopathic constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRUCALOPRIDE (Prucalopride)

Snippet

ORIG AP for PRUCALOPRIDE (PRUCALOPRIDE)